AFP Clinical Answers

Cervical Cancer, Febrile Seizures, HIV Infection, Dyspepsia

 

Am Fam Physician. 2019 Sep 15;100(6):331.

When should you stop screening for cervical cancer?

Evidence from randomized clinical trials and decision modeling studies suggests that screening beyond 65 years of age in women with adequate screening history would not have significant benefit. The current guidelines by the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology define adequate screening as three consecutive negative cytology results or two consecutive negative high-risk human papillomavirus results within 10 years before stopping screening, with the most recent test performed within five years. The U.S. Preventive Services Task Force recommends against screening for cervical cancer in women older than 65 years who have had adequate prior screening and are not otherwise at high risk for cervical cancer.

https://www.aafp.org/afp/2019/0215/p253.html

https://www.aafp.org/afp/2019/0215/od1.html

What are the risk factors for recurrent febrile seizures in children?

Risk factors for recurrence of febrile seizure are age younger than 18 months, fever duration of less than one hour before seizure onset, first-degree relative with a history of febrile seizures, and a temperature of less than 104°F (40°C).

https://www.aafp.org/afp/2019/0401/p445.html

What recommendations for initiating ART for HIV infection are supported by randomized controlled trials?

Unless a person has expressed interest in not initiating treatment, physicians should prescribe antiretroviral therapy (ART) immediately after HIV infection is diagnosed, including addressing treatment barriers to allow for ART initiation at the first office visit as appropriate. Most persons with opportunistic infections should receive ART within two weeks of diagnosis. Before starting treatment in any patient, HIV-1 RNA measurement; CD4 cell count; HIV genotyping for nucleoside reverse transcriptase inhibitors (NRTIs), non-NRTIs, and protease inhibitors; laboratory testing to identify active viral

 

 

Copyright © 2019 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions

CME Quiz

More in AFP


Editor's Collections


Related Content


More in Pubmed

MOST RECENT ISSUE


Oct 15, 2019

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article